Abstract
The objective of the present study was to investigate the antioxidant status and the extent of oxidative DNA damage in lymphocytes and their relation with essential hypertension (EHT). A total of 100 South Indian subjects aged 30–65 were included for the study. Of these 50 were normotensive controls (group-1) with blood pressure ≥120/80 mm Hg, 50 were newly diagnosed (group-2) and were not on any antihypertensive drugs, but had systolic blood pressure ranging between 140 and 160 mmHg and diastolic blood pressure 95–100 mmHg and 50 newly diagnosed essential hypertensive patients underwent drug therapy for 1 year was considered as group-3. Enzymatic and non-enzymatic antioxidants significantly decreased and lymphocyte DNA damage was significantly increased in newly diagnosed hypertensive patients compared with control group. The major decrease in DNA damage and significant improvement in enzymatic and non-enzymatic antioxidants were observed after 1 year of antihypertensive therapy in treated group compared with newly diagnosed hypertensive patients. Total antioxidant status and lymphocyte DNA damage showed a strong negative correlation in all the three groups. Essential hypertension associated with oxidative stress which in turn causes genotoxic susceptibility to variety of disease including cancer. In the absence of DNA repair process and DNA checkpoint mechanisms, the genomic integrity is susceptible to extensive damage. In our study, increased oxidative DNA damage and decreased antioxidant levels were frequently observed in the newly diagnosed essential hypertensive patients, suggesting that oxidative stress is important in the pathogenesis of EHT. Therefore, the present study has additional clinical implication. Further investigations with large number of patients along with antioxidant supplement are highly warranted.
Similar content being viewed by others
References
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA. 2003;289:2560–72.
De Bruyn VH, Nuns DW, Cappelli-Biggazzi M, Dole WR, Lamping KG. Effect of acute hypertension in the coronary vessels. J Hypertens. 1994;12:163–72.
Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep. 2010;12:135–42.
Makazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inow M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA. 1991;88:10045–8.
Hartmann A, Herkommer K, Gluck M, Speit G. DNA damaging effect of cyclophosphamide on human blood cells in vivo and in vitro studied with the single cell gel test (comet-assay). Environ Mol Mutagen. 1995;25:180–7.
Awara WM, El-Nabi SH, El-Gohary M. Assessment of vinyl chloride-induced DNA damage in lymphocytes of plastic industry workers using a single cell gel electrophoresis technique. Toxicology. 1998;128:9–16.
Halliwell B, Aruoma O. DNA damage by oxygen-derived species: its mechanism and measurement in mammalian systems. FEBS Lett. 1991;281:9–19.
Ames BN. Endogenous DNA damage as related to cancer and ageing. Free Radical Res Commun. 1989;7:121–8.
Botto N, Rizza A, Colombo MG, Mazzone AM, Manfredi S, Masetti S, et al. Evidence for DNA damage in patients with coronary artery disease. Mutat Res. 2001;493(1–2):23–30.
Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006;56:69–83.
Marvar PJ, Vinh A, Thabet S, et al. T-Lymphocytes and vascular inflammation contribute to stress-dependent hypertension. Biol Psychiatry. 2012;71(9):774–82.
Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. BioMed Res Int. 2014;2014:1–11.
Botto N, Masetti S, Petrozzi L, Vassalle C, Manfredi S, Biagini A, Andreassi MG. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis. 2002;13(5):269–74.
Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–8.
Omaye ST, Turnbull JD, Sauberlich HE. Selected methods for determination of ascorbic acid in cells, tissues and fluids. Methods Enzymol. 1979;62:3–11.
Desai ID. Vitamin E analysis method for animal tissues. Method Enzymol. 1984;105:138–42.
Sedlak J, Lindsay RH. Estimation of total protein bound and non protein sulphydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25:192–205.
Benzie IFF. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15–27.
Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med. 1975;85(2):337–41.
Aebi H. Catalase in vitro. Method enzyme. 1984;105:121–6.
Flohe L, Gunzler WA. Assay of glutathione peroxidase. In: Packer L, editor. Methods in enzymology. New York: Academic Press; 1984.
Coombes B, Stakelum GS. A liver enzyme that conjugates sulfobromophtalein with glutathione. J Clin Investig. 1961;40:981–8.
Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–8.
Singh PN, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184–91.
Burlinson B, Tice RR, Speit G, Agurell E, Brendler-Schwaab SY, Collins AR, et al. Fourth international workshop on genotoxicity testing: resulting of the in vivo comet assay workgroup. Mutat Res. 2007;627(1):31–5.
Erdogan C. The evaluation of oxidative stress in patients with CRF. CCA. 2002;322:157–67.
Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power. The FRAP assay. Anal Biochem. 1996;239:70–6.
Subash P, Gurumurthy P, Sarasabharathi A, Cherian KM. Urinary 8-OHdG: a marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population. Indian J Clin Biochem. 2010;25(2):127–32.
de la Sierra A, Larrousse M. Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension. J Hum Hypertens. 2010;24:373–9.
Juraschek SP, Guallar E, Appel LJ, Miller ER. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;95:1079–88.
Savica V, Bellinghieri G, Kopple JD. The effect of nutrition on blood pressure. Annu Rev Nutr. 2010;30:365–401.
Beg M, Gupta A, Khanna VN. Oxidative stress in essential hypertension and role of antioxidants. JIACM. 2010;11(4):287–93.
Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105:2107–11.
Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 2000;28:1815–26.
Kachhawa K, Varma M, Sahu A, Kachhawa P, Kumar R. Oxidative stress and antioxidant enzyme levels in hypertensive chronic kidney disease patients. IJBAR. 2004;5(10):488–90.
Gonzalez J, Valls N, Brito R, Rodrigo R. Essential hypertension and oxidative stress: new insights. World J Cardiol. 2014;6(6):353–66.
Rodrigo R, Gil D, Miranda-Merchak A, Kalantzidis G. Antihypertensive role of polyphenols. Adv Clin Chem. 2012;58:225–54.
Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, et al. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens. 1998;16:1267–71.
Prabha PS, Das UN, Koratkar R, Sagar PS, Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot Essent Fatty Acids. 1990;41:27–33.
Rodrigo R, Libuy M, Feliu F, Hasson D. Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers. 2013;35(6):773–90.
Biswas UK, Kumar A. A study on lipid profile, oxidative stress and carbonic anhydrase activity in patients with essential hypertension. J Clin Diagn Res. 2010;4:3414–20.
Chen LY, Nichols WW, Hendricks J, Mehta JL. Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am Heart J. 1995;129:211–8.
Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2-de-oxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk Res. 2000;24:461–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee. The study was approved by both research and ethics committee of our institute.
Informed consent
A fully informed consent was obtained from all the subjects prior to participation in the study.
Rights and permissions
About this article
Cite this article
Subash, P. Assessment of Oxidative DNA Damage by Alkaline Comet Assay in Human Essential Hypertension. Ind J Clin Biochem 31, 185–193 (2016). https://doi.org/10.1007/s12291-015-0521-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-015-0521-1